新華醫療(600587.SH):擬掛牌轉讓持有的華科創智16.67%股權
格隆匯7月2日丨新華醫療(600587.SH)公佈,公司擬通過產權交易中心公開掛牌方式轉讓公司所持有的參股公司北京華科創智健康科技股份有限公司(“華科創智”)16.67%的股權。
公吿顯示,華科創智的產品研發工作主要圍繞消化、呼吸等臨牀應用領域,研發用於胃癌、食道癌、腸癌檢查診斷的消化電子胃鏡、腸鏡、消化超聲電子內鏡及消化腔內高頻超聲設備等消化內鏡等產品,研發產品存在技術難度大、產品結構精密微細、研發研製週期長、投資規模大、研發風險高等特點。
此外,華科創智已取得電子胃鏡產品三類註冊證4個、電子腸鏡三類註冊證1個、內鏡冷光源產品二類註冊證2個,華科創智相關產品尚處於研發階段,短期內無法實現產業化生產和銷售,未來研發成果在產業化及市場開發等方面仍存在眾多不確定性。綜合考慮產品研發期限、研發投入、研究成果轉化等方面的因素,公司決定將華科創智16.67%股權通過公開掛牌轉讓的方式出售。
若本次掛牌轉讓完成,公司將退出該投資項目,有利於公司優化資產結構,集中資源拓展主營業務,符合公司發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.